424 related articles for article (PubMed ID: 25889927)
1. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of three miR-129 family members on gastric cancer.
Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
Nakano H; Yamada Y; Miyazawa T; Yoshida T
Int J Oncol; 2013 Jun; 42(6):1875-82. PubMed ID: 23588298
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
Peng DX; Luo M; Qiu LW; He YL; Wang XF
Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
[TBL] [Abstract][Full Text] [Related]
6. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
[TBL] [Abstract][Full Text] [Related]
7. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
8. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.
Zhang W; Wang Q; Yu M; Wu N; Wang H
Technol Cancer Res Treat; 2014 Apr; 13(2):161-8. PubMed ID: 23919393
[TBL] [Abstract][Full Text] [Related]
10. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
Tang R; Cui ZM; Lou YH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):846-50. PubMed ID: 23302126
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.
Li Q; Zhou L; Wang M; Wang N; Li C; Wang J; Qi L
Biomed Pharmacother; 2018 Feb; 98():636-642. PubMed ID: 29289838
[TBL] [Abstract][Full Text] [Related]
12. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
13. [Role of microRNA-21 in the proliferation and apoptosis of ovarian epithelial carcinoma cells].
Lou YH; Cui ZM; Wang FL; Yang XS
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):684-9. PubMed ID: 22176994
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
[TBL] [Abstract][Full Text] [Related]
15. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.
Hong F; Li Y; Xu Y; Zhu L
J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
Zhu J; Zhang S; Gu L; Di W
Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
[TBL] [Abstract][Full Text] [Related]
18. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance.
Ye G; Fu G; Cui S; Zhao S; Bernaudo S; Bai Y; Ding Y; Zhang Y; Yang BB; Peng C
J Cell Sci; 2011 Feb; 124(Pt 3):359-68. PubMed ID: 21224400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]